Kidney complications

D. M. Brown, G. A. Andres, T. H. Hostetter, Michael Mauer, R. Price, M. A. Venkatachalam

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Diabetic glomerulosclerosis in man and in all spontaneous-onset and chemically induced diabetes in experimental models is characterized by diffuse increase in mesangial matrix and glomerular basement membrane thickening. The most prominent features of the biochemical changes in the glomerular basement membrane are increase in the collagen-like components, decreased sialic acid, and increased glucosylation. However, the heterogeneity of the various glycoprotein components of the glomerular basement membrane and related components of the mesangium make comparative biochemistry difficult. Increased glomerular blood flow with no apparent alterations in the glomerular filtration coefficient in diabetes may be attributed to altered vascular control mechanisms which may include both hormonal mediation as well as changes in end-organ responsiveness. Although proteinuria is a common manifestation of diabetic involvement of the glomerulus, there is little biochemical or physiologic evidence as to the specific causes of increased glomerular filtration apparatus permeability. Further information as to the pathogenesis of diabetic vascular disease of the kidney and the ability to reverse pathologic changes by correction of the metabolic milieu will require analysis of carefully selected animal models. Particular care in experimental design must include the ability to integrate pathology, physiology, and biochemistry in each model in order to relate the information to human renal diabetic complications.

Original languageEnglish (US)
Pages (from-to)71-81
Number of pages11
JournalDiabetes
Volume31
Issue numberSuppl. 1
StatePublished - Dec 10 1982

Fingerprint

Glomerular Basement Membrane
Kidney
Biochemistry
Diabetic Angiopathies
Diabetic Nephropathies
N-Acetylneuraminic Acid
Diabetes Complications
Proteinuria
Blood Vessels
Permeability
Glycoproteins
Research Design
Theoretical Models
Collagen
Animal Models
Pathology

Cite this

Brown, D. M., Andres, G. A., Hostetter, T. H., Mauer, M., Price, R., & Venkatachalam, M. A. (1982). Kidney complications. Diabetes, 31(Suppl. 1), 71-81.

Kidney complications. / Brown, D. M.; Andres, G. A.; Hostetter, T. H.; Mauer, Michael; Price, R.; Venkatachalam, M. A.

In: Diabetes, Vol. 31, No. Suppl. 1, 10.12.1982, p. 71-81.

Research output: Contribution to journalArticle

Brown, DM, Andres, GA, Hostetter, TH, Mauer, M, Price, R & Venkatachalam, MA 1982, 'Kidney complications', Diabetes, vol. 31, no. Suppl. 1, pp. 71-81.
Brown DM, Andres GA, Hostetter TH, Mauer M, Price R, Venkatachalam MA. Kidney complications. Diabetes. 1982 Dec 10;31(Suppl. 1):71-81.
Brown, D. M. ; Andres, G. A. ; Hostetter, T. H. ; Mauer, Michael ; Price, R. ; Venkatachalam, M. A. / Kidney complications. In: Diabetes. 1982 ; Vol. 31, No. Suppl. 1. pp. 71-81.
@article{eef5c33a773a491cb4c78eb17cddc0ff,
title = "Kidney complications",
abstract = "Diabetic glomerulosclerosis in man and in all spontaneous-onset and chemically induced diabetes in experimental models is characterized by diffuse increase in mesangial matrix and glomerular basement membrane thickening. The most prominent features of the biochemical changes in the glomerular basement membrane are increase in the collagen-like components, decreased sialic acid, and increased glucosylation. However, the heterogeneity of the various glycoprotein components of the glomerular basement membrane and related components of the mesangium make comparative biochemistry difficult. Increased glomerular blood flow with no apparent alterations in the glomerular filtration coefficient in diabetes may be attributed to altered vascular control mechanisms which may include both hormonal mediation as well as changes in end-organ responsiveness. Although proteinuria is a common manifestation of diabetic involvement of the glomerulus, there is little biochemical or physiologic evidence as to the specific causes of increased glomerular filtration apparatus permeability. Further information as to the pathogenesis of diabetic vascular disease of the kidney and the ability to reverse pathologic changes by correction of the metabolic milieu will require analysis of carefully selected animal models. Particular care in experimental design must include the ability to integrate pathology, physiology, and biochemistry in each model in order to relate the information to human renal diabetic complications.",
author = "Brown, {D. M.} and Andres, {G. A.} and Hostetter, {T. H.} and Michael Mauer and R. Price and Venkatachalam, {M. A.}",
year = "1982",
month = "12",
day = "10",
language = "English (US)",
volume = "31",
pages = "71--81",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "Suppl. 1",

}

TY - JOUR

T1 - Kidney complications

AU - Brown, D. M.

AU - Andres, G. A.

AU - Hostetter, T. H.

AU - Mauer, Michael

AU - Price, R.

AU - Venkatachalam, M. A.

PY - 1982/12/10

Y1 - 1982/12/10

N2 - Diabetic glomerulosclerosis in man and in all spontaneous-onset and chemically induced diabetes in experimental models is characterized by diffuse increase in mesangial matrix and glomerular basement membrane thickening. The most prominent features of the biochemical changes in the glomerular basement membrane are increase in the collagen-like components, decreased sialic acid, and increased glucosylation. However, the heterogeneity of the various glycoprotein components of the glomerular basement membrane and related components of the mesangium make comparative biochemistry difficult. Increased glomerular blood flow with no apparent alterations in the glomerular filtration coefficient in diabetes may be attributed to altered vascular control mechanisms which may include both hormonal mediation as well as changes in end-organ responsiveness. Although proteinuria is a common manifestation of diabetic involvement of the glomerulus, there is little biochemical or physiologic evidence as to the specific causes of increased glomerular filtration apparatus permeability. Further information as to the pathogenesis of diabetic vascular disease of the kidney and the ability to reverse pathologic changes by correction of the metabolic milieu will require analysis of carefully selected animal models. Particular care in experimental design must include the ability to integrate pathology, physiology, and biochemistry in each model in order to relate the information to human renal diabetic complications.

AB - Diabetic glomerulosclerosis in man and in all spontaneous-onset and chemically induced diabetes in experimental models is characterized by diffuse increase in mesangial matrix and glomerular basement membrane thickening. The most prominent features of the biochemical changes in the glomerular basement membrane are increase in the collagen-like components, decreased sialic acid, and increased glucosylation. However, the heterogeneity of the various glycoprotein components of the glomerular basement membrane and related components of the mesangium make comparative biochemistry difficult. Increased glomerular blood flow with no apparent alterations in the glomerular filtration coefficient in diabetes may be attributed to altered vascular control mechanisms which may include both hormonal mediation as well as changes in end-organ responsiveness. Although proteinuria is a common manifestation of diabetic involvement of the glomerulus, there is little biochemical or physiologic evidence as to the specific causes of increased glomerular filtration apparatus permeability. Further information as to the pathogenesis of diabetic vascular disease of the kidney and the ability to reverse pathologic changes by correction of the metabolic milieu will require analysis of carefully selected animal models. Particular care in experimental design must include the ability to integrate pathology, physiology, and biochemistry in each model in order to relate the information to human renal diabetic complications.

UR - http://www.scopus.com/inward/record.url?scp=0020067629&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020067629&partnerID=8YFLogxK

M3 - Article

C2 - 7160536

AN - SCOPUS:0020067629

VL - 31

SP - 71

EP - 81

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - Suppl. 1

ER -